FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
FDA and USDA among federal agencies aiming to rehire workers hit by mass firings
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...
Smokescreen: some vape firms pivot after FDA crackdown
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
Yahoo Finance4d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...
usace.army.mil10h
Not all Kisses are Sweet; Expert Advice on Chagas Disease
Every summer, an insect with a sweet name poses a serious threat to the populations of the southern United States and Latin America.
So Much For RFK, Jr.'s Promise of 'Radical Transparency' at HHS
The Health and Human Service's secretary has inexplicably cancelled two vaccine-related advisory meetings since taking the helm of the agency.
Hosted on MSN9h
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More
Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.